CONTEXT: Delayed menarche is associated with subsequent reproductive and skeletal complications. Previous research has found delayed growth and pubertal maturation with type 1 diabetes and poor glycemic control. The effect of diabetes management on menarche is important to clarify, because tighter control might prevent these complications. OBJECTIVE: The objective of this study was to investigate age at menarche in young women with type 1 diabetes and examine the effect of diabetes management [e.g. total glycosylated hemoglobin (GHb) level, number of blood glucose checks, insulin therapy intensity, and insulin dose] on age at menarche in those diagnosed before menarche. DESIGN: The Wisconsin Diabetes Registry Project is a follow-up study of a type 1 diabetes population-based incident cohort initially enrolled between 1987 and 1992. SETTING: This study was performed in 28 counties in south-central Wisconsin. PATIENTS OR OTHER PARTICIPANTS: The study participants were recruited through referrals, self-report, and hospital/clinic ascertainment. Individuals with newly diagnosed type 1 diabetes, less than 30 yr old, were invited to participate. Of 288 young women enrolled, 188 reported menarche by 2002; 105 were diagnosed before menarche. INTERVENTIONS: There were no interventions. MAIN OUTCOME MEASURE: The main outcome measure was age at menarche. RESULTS: Mean age at menarche was 12.78 yr, compared with 12.54 yr in the United States (P = 0.01). Ages at menarche and diagnosis were not associated. For those diagnosed before menarche, age at menarche was delayed 1.3 months with each 1% increase in mean total GHb level in the 3 yr before menarche. CONCLUSIONS: Age at menarche was moderately delayed in young women with type 1 diabetes. Delayed menarche could potentially be minimized with improved GHb levels.
CONTEXT: Delayed menarche is associated with subsequent reproductive and skeletal complications. Previous research has found delayed growth and pubertal maturation with type 1 diabetes and poor glycemic control. The effect of diabetes management on menarche is important to clarify, because tighter control might prevent these complications. OBJECTIVE: The objective of this study was to investigate age at menarche in young women with type 1 diabetes and examine the effect of diabetes management [e.g. total glycosylated hemoglobin (GHb) level, number of blood glucose checks, insulin therapy intensity, and insulin dose] on age at menarche in those diagnosed before menarche. DESIGN: The Wisconsin Diabetes Registry Project is a follow-up study of a type 1 diabetes population-based incident cohort initially enrolled between 1987 and 1992. SETTING: This study was performed in 28 counties in south-central Wisconsin. PATIENTS OR OTHER PARTICIPANTS: The study participants were recruited through referrals, self-report, and hospital/clinic ascertainment. Individuals with newly diagnosed type 1 diabetes, less than 30 yr old, were invited to participate. Of 288 young women enrolled, 188 reported menarche by 2002; 105 were diagnosed before menarche. INTERVENTIONS: There were no interventions. MAIN OUTCOME MEASURE: The main outcome measure was age at menarche. RESULTS: Mean age at menarche was 12.78 yr, compared with 12.54 yr in the United States (P = 0.01). Ages at menarche and diagnosis were not associated. For those diagnosed before menarche, age at menarche was delayed 1.3 months with each 1% increase in mean total GHb level in the 3 yr before menarche. CONCLUSIONS: Age at menarche was moderately delayed in young women with type 1 diabetes. Delayed menarche could potentially be minimized with improved GHb levels.
Authors: B Zumoff; L Miller; L Poretsky; C D Levit; E H Miller; U Heinz; H Denman; R Jandorek; R S Rosenfeld Journal: Steroids Date: 1990-12 Impact factor: 2.668
Authors: Mari Palta; Tamara J LeCaire; Mona Sadek-Badawi; Victor M Herrera; Kirstie K Danielson Journal: Diabetes Metab Res Rev Date: 2014-11 Impact factor: 4.876
Authors: Yan Yi; Samar R El Khoudary; Jeanine M Buchanich; Rachel G Miller; Debra Rubinstein; Karen Matthews; Trevor J Orchard; Tina Costacou Journal: Menopause Date: 2021-03-01 Impact factor: 3.310
Authors: M Plamper; B Gohlke; J Woelfle; K Konrad; T Rohrer; S Hofer; W Bonfig; K Fink; R W Holl Journal: J Diabetes Res Date: 2017-11-07 Impact factor: 4.011